Texas Capital Bank Wealth Management Services’s Cytosorbents Corp CTSO Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.23K	Hold	11,000	–	–	﹤0.01%	345
2025 Q4	$7.03K	Buy	+11,000	New	+$8.46K	﹤0.01%	338
2024 Q4	–	Sell	-23,166	Closed	-$34.7K	–	172
2024 Q3	$34.7K	Hold	23,166	–	–	﹤0.01%	196
2024 Q2	$16.3K	Hold	23,166	–	–	﹤0.01%	198
2024 Q1	$22K	Sell	23,166 -7,500	-24%	-$7.3K	﹤0.01%	196
2023 Q4	$34K	Hold	30,666	–	–	﹤0.01%	199
2023 Q3	$57.7K	Sell	30,666 -6,073	-17%	-$17.4K	0.01%	202
2023 Q2	$132K	Sell	36,739 -886	-2%	-$2.8K	0.01%	215
2023 Q1	$127K	Sell	37,625 -11,333	-23%	-$34K	0.01%	179
2022 Q4	$75.9K	Hold	48,958	–	–	0.01%	162
2022 Q3	$67K	Hold	48,958	–	–	0.01%	143
2022 Q2	$107K	Buy	+48,958	New	+$112K	0.01%	142

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Texas Capital Bank Wealth Management Services's CTSO Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 11,000 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

Texas Capital Bank Wealth Management Services first reported a position in CTSO in Q2 2022 and has held it in 12 quarters since. The position peaked at $132K in Q2 2023. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

Texas Capital Bank Wealth Management Services held 11,000 shares of Cytosorbents Corp worth $6.23K as of Q1 2026.
Texas Capital Bank Wealth Management Services left its Cytosorbents Corp share count unchanged in Q1 2026.
Cytosorbents Corp made up ﹤0.01% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #345 holding.
Texas Capital Bank Wealth Management Services first reported a position in Cytosorbents Corp in Q2 2022 and has held it in 12 quarters since.
Texas Capital Bank Wealth Management Services's Cytosorbents Corp position peaked at $132K in Q2 2023.
50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.